These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 11130385)

  • 21. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).
    Boggild AK; Parise ME; Lewis LS; Kain KC
    Am J Trop Med Hyg; 2007 Feb; 76(2):208-23. PubMed ID: 17297027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atovaquone-proguanil (malarone): an effective treatment for uncomplicated Plasmodium falciparum malaria in travelers from Denmark.
    Thybo S; Gjorup I; Ronn AM; Meyrowitsch D; Bygberg IC
    J Travel Med; 2004; 11(4):220-3. PubMed ID: 15541224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.
    Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G
    Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of atovaquone and proguanil hydrochloride for the prophylaxis of Plasmodium falciparum malaria in South Africa.
    van der Berg JD; Duvenage CS; Roskell NS; Scott TR
    Clin Ther; 1999 Apr; 21(4):741-9. PubMed ID: 10363739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Malaria--chemoprophylaxis 2001].
    Hatz FR; Beck B; Blum J; Funk M; Furrer H; Genton B; Holzer B; Loutan L; Markwalder K; Raeber PA; Schlagenhauf P; Siegl G; Steffen R; Stürchler D; Wyss R
    Ther Umsch; 2001 Jun; 58(6):347-51. PubMed ID: 11441694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults.
    Petersen E
    J Travel Med; 2003 May; 10 Suppl 1():S13-5; discussion S21. PubMed ID: 12737755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causal prophylactic efficacy of atovaquone-proguanil (Malarone) in a human challenge model.
    Berman JD; Nielsen R; Chulay JD; Dowler M; Kain KC; Kester KE; Williams J; Whelen AC; Shmuklarsky MJ
    Trans R Soc Trop Med Hyg; 2001; 95(4):429-32. PubMed ID: 11579890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.
    Na-Bangchang K; Manyando C; Ruengweerayut R; Kioy D; Mulenga M; Miller GB; Konsil J
    Eur J Clin Pharmacol; 2005 Sep; 61(8):573-82. PubMed ID: 16041597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atovaquone and proguanil for Plasmodium falciparum malaria.
    Radloff PD; Philipps J; Nkeyi M; Hutchinson D; Kremsner PG
    Lancet; 1996 Jun; 347(9014):1511-4. PubMed ID: 8684102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries.
    Overbosch D
    J Travel Med; 2003 May; 10 Suppl 1():S16-20; discussion S21-3. PubMed ID: 12737756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
    Lachish T; Bar-Meir M; Eisenberg N; Schwartz E
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malaria chemoprophylaxis].
    Petersen JE
    Ugeskr Laeger; 2005 Oct; 167(42):3984-7. PubMed ID: 16232397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine.
    Enosse S; Butcher GA; Margos G; Mendoza J; Sinden RE; Høgh B
    Trans R Soc Trop Med Hyg; 2000; 94(1):77-82. PubMed ID: 10748906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [What is the value of the combination atovaquone-proguanil for the clinician?].
    Delmont J
    Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Atovaquone/proguanil. Prophylaxis and treatment of malaria].
    Lundgren JD; Dragsted UB
    Ugeskr Laeger; 2000 Jul; 162(31):4177-81. PubMed ID: 10962933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria.
    Nakato H; Vivancos R; Hunter PR
    J Antimicrob Chemother; 2007 Nov; 60(5):929-36. PubMed ID: 17848375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atovaquone-proguanil for treating uncomplicated malaria.
    Osei-Akoto A; Orton L; Owusu-Ofori SP
    Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD004529. PubMed ID: 16235366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.